Infectious Disease Billing and Insurance in Washington

Revenue cycle management follows the financial path of care from referral and eligibility through documentation, coding, authorization, claim submission, payment, denial resolution, and accounts receivable follow-up. In infectious disease, the workflow may also include infusion administration, drug claims, OPAT services, and different benefit structures. Reviewing the full cycle helps practices identify where revenue is delayed, lost, underpaid, or left uncollected.

Washington infectious disease practices should review documentation, coding, authorization, benefit classification, drug and administration charge capture, payer contracts, claim submission, denials, payment accuracy, and aging accounts receivable. Practices providing office visits, hospital consults, infusion, or OPAT may have different billing workflows. A structured review can show whether financial issues originate in clinical documentation, front-office processes, payer rules, contracts, or follow-up.

Denial reduction starts with categorizing denials by root cause rather than treating every rejected claim the same way. Common review areas include drug and administration coding, missing authorization, medical versus pharmacy benefit handling, and incomplete consult documentation. Findings can be shared with clinical, coding, and front-office teams so the underlying workflow is corrected and payer-specific appeal information is prepared consistently.

Infusion and OPAT may combine clinical services, drug acquisition, administration, authorization, eligibility, and payer benefit rules. A practice must understand which services and products require separate documentation or billing treatment, while also tracking whether reimbursement matches the work and drug charges involved. Reviewing the workflow from referral through final payment can expose gaps that are not visible in a basic claim total.

Payment reconciliation compares payer payments with the reimbursement expected under applicable fee schedules, contracts, and claim details. For infectious disease practices, the review may include drug, infusion administration, and evaluation and management claims. It can identify short-pays, incorrect fee schedule application, unit mismatches, NDC issues, and other discrepancies requiring dispute, follow-up, or contract review.

Payer enrollment may involve CAQH, commercial and government payer applications, re-credentialing, and enrollment for each relevant provider, site, and service. Independent infectious disease practices should consider separate revenue streams such as office visits, hospital consults, infusion, and contracted services. Organizing enrollment around the actual services and locations helps support billable operations from the start.

Revenue leakage can occur before a claim is sent through under-leveled visits, missing drug or administration charges, incomplete documentation, or uncaptured services. It can also arise later through denials, underpayments, aging balances, or contract noncompliance. Reporting by payer, service line, and provider helps connect financial patterns to their source and gives practice leaders a basis for prioritized workflow improvements.

GrowInfectiousDisease does not publish invented rates, drug acquisition costs, payment rates, or margin figures. Reimbursement depends on the practice, payer, contract, service, documentation, and applicable billing circumstances. The tools and explanations are designed to help users apply their own numbers, evaluate revenue streams, and understand financial mechanics without treating generalized figures as a substitute for practice-specific analysis.